1
|
Ma Y, Shi Z, Wei Y, Shi F, Qin G, Zhou Z. Exploring the value of multiple preprocessors and classifiers in constructing models for predicting microsatellite instability status in colorectal cancer. Sci Rep 2024; 14:20305. [PMID: 39218940 PMCID: PMC11366760 DOI: 10.1038/s41598-024-71420-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2024] [Accepted: 08/28/2024] [Indexed: 09/04/2024] Open
Abstract
Approximately 15% of patients with colorectal cancer (CRC) exhibit a distinct molecular phenotype known as microsatellite instability (MSI). Accurate and non-invasive prediction of MSI status is crucial for cost savings and guiding clinical treatment strategies. The retrospective study enrolled 307 CRC patients between January 2020 and October 2022. Preoperative images of computed tomography and postoperative status of MSI information were available for analysis. The stratified fivefold cross-validation was used to avoid sample bias in grouping. Feature extraction and model construction were performed as follows: first, inter-/intra-correlation coefficients and the least absolute shrinkage and selection operator algorithm were used to identify the most predictive feature subset. Subsequently, multiple discriminant models were constructed to explore and optimize the combination of six feature preprocessors (Box-Cox, Yeo-Johnson, Max-Abs, Min-Max, Z-score, and Quantile) and three classifiers (logistic regression, support vector machine, and random forest). Selecting the one with the highest average value of the area under the curve (AUC) in the test set as the radiomics model, and the clinical screening model and combined model were also established using the same processing steps as the radiomics model. Finally, the performances of the three models were evaluated and analyzed using decision and correction curves.We observed that the logistic regression model based on the quantile preprocessor had the highest average AUC value in the discriminant models. Additionally, tumor location, the clinical of N stage, and hypertension were identified as independent clinical predictors of MSI status. In the test set, the clinical screening model demonstrated good predictive performance, with the average AUC of 0.762 (95% confidence interval, 0.635-0.890). Furthermore, the combined model showed excellent predictive performance (AUC, 0.958; accuracy, 0.899; sensitivity, 0.929) and favorable clinical applicability and correction effects. The logistic regression model based on the quantile preprocessor exhibited excellent performance and repeatability, which may further reduce the variability of input data and improve the model performance for predicting MSI status in CRC.
Collapse
Affiliation(s)
- Yi Ma
- Department of Radiology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, No. 321 Zhongshan Road, Nanjing, 210008, Jiangsu Province, China
| | - Zhihao Shi
- Department of Radiology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, No. 321 Zhongshan Road, Nanjing, 210008, Jiangsu Province, China
| | - Ying Wei
- Department of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., 701 Yunjin Rd, Xuhui District, Shanghai, 200232, China
| | - Feng Shi
- Department of Research and Development, Shanghai United Imaging Intelligence Co., Ltd., 701 Yunjin Rd, Xuhui District, Shanghai, 200232, China
| | - Guochu Qin
- Department of Radiology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, No. 321 Zhongshan Road, Nanjing, 210008, Jiangsu Province, China.
| | - Zhengyang Zhou
- Department of Radiology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, No. 321 Zhongshan Road, Nanjing, 210008, Jiangsu Province, China.
| |
Collapse
|
2
|
Hinzpeter R, Mirshahvalad SA, Murad V, Avery L, Kulanthaivelu R, Kohan A, Ortega C, Elimova E, Yeung J, Hope A, Metser U, Veit-Haibach P. The [ 18F]F-FDG PET/CT Radiomics Classifier of Histologic Subtypes and Anatomical Disease Origins across Various Malignancies: A Proof-of-Principle Study. Cancers (Basel) 2024; 16:1873. [PMID: 38791955 PMCID: PMC11119256 DOI: 10.3390/cancers16101873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2024] [Revised: 05/09/2024] [Accepted: 05/14/2024] [Indexed: 05/26/2024] Open
Abstract
We aimed to investigate whether [18F]F-FDG-PET/CT-derived radiomics can classify histologic subtypes and determine the anatomical origin of various malignancies. In this IRB-approved retrospective study, 391 patients (age = 66.7 ± 11.2) with pulmonary (n = 142), gastroesophageal (n = 128) and head and neck (n = 121) malignancies were included. Image segmentation and feature extraction were performed semi-automatically. Two models (all possible subset regression [APS] and recursive partitioning) were employed to predict histology (squamous cell carcinoma [SCC; n = 219] vs. adenocarcinoma [AC; n = 172]), the anatomical origin, and histology plus anatomical origin. The recursive partitioning algorithm outperformed APS to determine histology (sensitivity 0.90 vs. 0.73; specificity 0.77 vs. 0.65). The recursive partitioning algorithm also revealed good predictive ability regarding anatomical origin. Particularly, pulmonary malignancies were identified with high accuracy (sensitivity 0.93; specificity 0.98). Finally, a model for the synchronous prediction of histology and anatomical disease origin resulted in high accuracy in determining gastroesophageal AC (sensitivity 0.88; specificity 0.92), pulmonary AC (sensitivity 0.89; specificity 0.88) and head and neck SCC (sensitivity 0.91; specificity 0.92). Adding PET-features was associated with marginal incremental value for both the prediction of histology and origin in the APS model. Overall, our study demonstrated a good predictive ability to determine patients' histology and anatomical origin using [18F]F-FDG-PET/CT-derived radiomics features, mainly from CT.
Collapse
Affiliation(s)
- Ricarda Hinzpeter
- University Medical Imaging Toronto, Joint Department Medical Imaging, University Health Network, Sinai Health System, Women’s College Hospital, University of Toronto, Toronto, ON M5G 2N2, Canada; (S.A.M.); (V.M.); (R.K.); (A.K.); (C.O.); (U.M.); (P.V.-H.)
- Institute for Diagnostic and Interventional Radiology, University Hospital Zurich, 8091 Zurich, Switzerland
| | - Seyed Ali Mirshahvalad
- University Medical Imaging Toronto, Joint Department Medical Imaging, University Health Network, Sinai Health System, Women’s College Hospital, University of Toronto, Toronto, ON M5G 2N2, Canada; (S.A.M.); (V.M.); (R.K.); (A.K.); (C.O.); (U.M.); (P.V.-H.)
| | - Vanessa Murad
- University Medical Imaging Toronto, Joint Department Medical Imaging, University Health Network, Sinai Health System, Women’s College Hospital, University of Toronto, Toronto, ON M5G 2N2, Canada; (S.A.M.); (V.M.); (R.K.); (A.K.); (C.O.); (U.M.); (P.V.-H.)
| | - Lisa Avery
- Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 1X6, Canada;
- Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada
| | - Roshini Kulanthaivelu
- University Medical Imaging Toronto, Joint Department Medical Imaging, University Health Network, Sinai Health System, Women’s College Hospital, University of Toronto, Toronto, ON M5G 2N2, Canada; (S.A.M.); (V.M.); (R.K.); (A.K.); (C.O.); (U.M.); (P.V.-H.)
| | - Andres Kohan
- University Medical Imaging Toronto, Joint Department Medical Imaging, University Health Network, Sinai Health System, Women’s College Hospital, University of Toronto, Toronto, ON M5G 2N2, Canada; (S.A.M.); (V.M.); (R.K.); (A.K.); (C.O.); (U.M.); (P.V.-H.)
| | - Claudia Ortega
- University Medical Imaging Toronto, Joint Department Medical Imaging, University Health Network, Sinai Health System, Women’s College Hospital, University of Toronto, Toronto, ON M5G 2N2, Canada; (S.A.M.); (V.M.); (R.K.); (A.K.); (C.O.); (U.M.); (P.V.-H.)
| | - Elena Elimova
- Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2C4, Canada;
| | - Jonathan Yeung
- Division of Thoracic Surgery, Department of Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON M5G 2C4, Canada;
| | - Andrew Hope
- Department of Radiation Oncology, University Health Network, Toronto, ON M5G 2C4, Canada;
| | - Ur Metser
- University Medical Imaging Toronto, Joint Department Medical Imaging, University Health Network, Sinai Health System, Women’s College Hospital, University of Toronto, Toronto, ON M5G 2N2, Canada; (S.A.M.); (V.M.); (R.K.); (A.K.); (C.O.); (U.M.); (P.V.-H.)
| | - Patrick Veit-Haibach
- University Medical Imaging Toronto, Joint Department Medical Imaging, University Health Network, Sinai Health System, Women’s College Hospital, University of Toronto, Toronto, ON M5G 2N2, Canada; (S.A.M.); (V.M.); (R.K.); (A.K.); (C.O.); (U.M.); (P.V.-H.)
| |
Collapse
|
3
|
Çalışkan M, Tazaki K. AI/ML advances in non-small cell lung cancer biomarker discovery. Front Oncol 2023; 13:1260374. [PMID: 38148837 PMCID: PMC10750392 DOI: 10.3389/fonc.2023.1260374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Accepted: 11/16/2023] [Indexed: 12/28/2023] Open
Abstract
Lung cancer is the leading cause of cancer deaths among both men and women, representing approximately 25% of cancer fatalities each year. The treatment landscape for non-small cell lung cancer (NSCLC) is rapidly evolving due to the progress made in biomarker-driven targeted therapies. While advancements in targeted treatments have improved survival rates for NSCLC patients with actionable biomarkers, long-term survival remains low, with an overall 5-year relative survival rate below 20%. Artificial intelligence/machine learning (AI/ML) algorithms have shown promise in biomarker discovery, yet NSCLC-specific studies capturing the clinical challenges targeted and emerging patterns identified using AI/ML approaches are lacking. Here, we employed a text-mining approach and identified 215 studies that reported potential biomarkers of NSCLC using AI/ML algorithms. We catalogued these studies with respect to BEST (Biomarkers, EndpointS, and other Tools) biomarker sub-types and summarized emerging patterns and trends in AI/ML-driven NSCLC biomarker discovery. We anticipate that our comprehensive review will contribute to the current understanding of AI/ML advances in NSCLC biomarker research and provide an important catalogue that may facilitate clinical adoption of AI/ML-derived biomarkers.
Collapse
Affiliation(s)
- Minal Çalışkan
- Translational Science Department, Precision Medicine Function, Daiichi Sankyo, Inc., Basking Ridge, NJ, United States
| | - Koichi Tazaki
- Translational Science Department I, Precision Medicine Function, Daiichi Sankyo, Tokyo, Japan
| |
Collapse
|
4
|
Liu X, Zou Q, Sun Y, Liu H, Cailiang G. Role of multiple dual-phase 18F-FDG PET/CT metabolic parameters in differentiating adenocarcinomas from squamous cell carcinomas of the lung. Heliyon 2023; 9:e20180. [PMID: 37767476 PMCID: PMC10520777 DOI: 10.1016/j.heliyon.2023.e20180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2023] [Revised: 09/06/2023] [Accepted: 09/13/2023] [Indexed: 09/29/2023] Open
Abstract
Purpose To evaluate the ability of multiple dual-phase 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) metabolic parameters to distinguish the histological subtypes of non-small cell lung cancer (NSCLC). Methods Data from 127 patients with non-small cell lung cancer who underwent preoperative dual-phase 18F-FDG PET/CT scanning at the PET-CT center of our hospital from December 2020 to October 2021 were collected, and the metabolic parameters of their primary lesions were measured and analyzed retrospectively. Intraclass correlation coefficients (ICC) were calculated for consistency between readers. Metabolic parameters in the early (SUVpeak, SUVmean, SUVmin, SUVmax, MTV, and TLG) and delayed phases (dpSUVpeak, dpSUVmean, dpSUVmin, dpSUVmax, dpMTV, and dpTLG) were calculated. We drew receiver operating characteristic (ROC) curves to compare the differences in different metabolic parameters between the adenocarcinoma (AC) and squamous cell carcinoma (SCC) groups and evaluated the ability of different metabolic parameters to distinguish AC from SCC. Results Inter-reader agreement, as assessed by the intraclass correlation coefficient (ICC), was good (ICC = 0.71, 95% CI:0.60-0.79). The mean MTV, SUVmax, TLG, SUVpeak, SUVmean, dpSUVmax, dpTLG, dpSUVpeak, dpSUVmean, and dpSUVmin of the tumors were significantly higher in SCC lesions than in AC lesions (P = 0.049, < 0.001, 0.016, < 0.001, 0.001, < 0.001, 0.018, < 0.001, 0.001, and 0.001, respectively). The diagnostic efficacy of the metabolic parameters in 18F-FDG PET/CT for differentiating adenocarcinoma from squamous cell carcinoma ranged from high to low as follows: SUVpeak (AUC = 0.727), SUVmax (AUC = 0.708), dpSUVmax (AUC = 0.699), dpSUVpeak (AUC = 0.698), TLG (AUC = 0.695), and dpTLG (AUC = 0.692), SUVmean (AUC = 0.690), dpSUVmean (AUC = 0.687), dpSUVmin (AUC = 0.680), SUVmin (AUC = 0.676), and MTV (AUC = 0.657). Conclusions Squamous cell carcinoma of the lung had higher mean MTV, SUVmax, TLG, SUVpeak, SUVmean, SUVmin, dpSUVpeak, dpSUVmean, dpSUVmin, dpSUVmax, and dpTLG than AC, which can be helpful tools in differentiating between the two. The metabolic parameters of the delayed phase (2 h after injection) 18F-FDG PET/CT did not improve the diagnostic efficacy in distinguishing lung AC from SCC. Conventional dual-phase 18F-FDG PET/CT is not recommended.
Collapse
Affiliation(s)
| | | | - Yu Sun
- Department of Nuclear Medicine, Chongqing University Three Gorges Hospital, Wanzhou, 404100, Chongqing, China
| | - Huiting Liu
- Department of Nuclear Medicine, Chongqing University Three Gorges Hospital, Wanzhou, 404100, Chongqing, China
| | - Gao Cailiang
- Department of Nuclear Medicine, Chongqing University Three Gorges Hospital, Wanzhou, 404100, Chongqing, China
| |
Collapse
|
5
|
Zarella MD, McClintock DS, Batra H, Gullapalli RR, Valante M, Tan VO, Dayal S, Oh KS, Lara H, Garcia CA, Abels E. Artificial intelligence and digital pathology: clinical promise and deployment considerations. J Med Imaging (Bellingham) 2023; 10:051802. [PMID: 37528811 PMCID: PMC10389766 DOI: 10.1117/1.jmi.10.5.051802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2023] [Revised: 06/02/2023] [Accepted: 06/29/2023] [Indexed: 08/03/2023] Open
Abstract
Artificial intelligence (AI) presents an opportunity in anatomic pathology to provide quantitative objective support to a traditionally subjective discipline, thereby enhancing clinical workflows and enriching diagnostic capabilities. AI requires access to digitized pathology materials, which, at present, are most commonly generated from the glass slide using whole-slide imaging. Models are developed collaboratively or sourced externally, and best practices suggest validation with internal datasets most closely resembling the data expected in practice. Although an array of AI models that provide operational support for pathology practices or improve diagnostic quality and capabilities has been described, most of them can be categorized into one or more discrete types. However, their function in the pathology workflow can vary, as a single algorithm may be appropriate for screening and triage, diagnostic assistance, virtual second opinion, or other uses depending on how it is implemented and validated. Despite the clinical promise of AI, the barriers to adoption have been numerous, to which inclusion of new stakeholders and expansion of reimbursement opportunities may be among the most impactful solutions.
Collapse
Affiliation(s)
- Mark D. Zarella
- Mayo Clinic, Division of Computational Pathology and AI, Department of Laboratory Medicine and Pathology, Rochester, Minnesota, United States
| | - David S. McClintock
- Mayo Clinic, Division of Computational Pathology and AI, Department of Laboratory Medicine and Pathology, Rochester, Minnesota, United States
| | - Harsh Batra
- University of Texas MD Anderson Cancer Center, Department of Translational Molecular Pathology, Houston, Texas, United States
| | - Rama R. Gullapalli
- University of New Mexico, Department of Pathology, Albuquerque, New Mexico, United States
- University of New Mexico, Chemical and Biological Engineering, Albuquerque, New Mexico, United States
| | - Michael Valante
- Dell Technologies, Unstructured Data Solutions, Hopkinton, Massachusetts, United States
| | - Vivian O. Tan
- Leica Biosystems, Medical and Scientific Affairs, Vista, California, United States
| | - Shubham Dayal
- Leica Biosystems, Medical and Scientific Affairs, Danvers, Massachusetts, United States
| | - Kei Shing Oh
- Mount Sinai Medical Center, Miami Beach, Florida, United States
| | - Haydee Lara
- Biomarker Development, Alexion-AstraZeneca Rare Disease Unit, New Haven, Connecticut, United States
| | - Chris A. Garcia
- Mayo Clinic, Division of Computational Pathology and AI, Department of Laboratory Medicine and Pathology, Rochester, Minnesota, United States
| | - Esther Abels
- SolarisRTC LLC, Boston, Massachusetts, United States
| |
Collapse
|
6
|
Dunn B, Pierobon M, Wei Q. Automated Classification of Lung Cancer Subtypes Using Deep Learning and CT-Scan Based Radiomic Analysis. Bioengineering (Basel) 2023; 10:690. [PMID: 37370621 DOI: 10.3390/bioengineering10060690] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2023] [Revised: 06/02/2023] [Accepted: 06/03/2023] [Indexed: 06/29/2023] Open
Abstract
Artificial intelligence and emerging data science techniques are being leveraged to interpret medical image scans. Traditional image analysis relies on visual interpretation by a trained radiologist, which is time-consuming and can, to some degree, be subjective. The development of reliable, automated diagnostic tools is a key goal of radiomics, a fast-growing research field which combines medical imaging with personalized medicine. Radiomic studies have demonstrated potential for accurate lung cancer diagnoses and prognostications. The practice of delineating the tumor region of interest, known as segmentation, is a key bottleneck in the development of generalized classification models. In this study, the incremental multiple resolution residual network (iMRRN), a publicly available and trained deep learning segmentation model, was applied to automatically segment CT images collected from 355 lung cancer patients included in the dataset "Lung-PET-CT-Dx", obtained from The Cancer Imaging Archive (TCIA), an open-access source for radiological images. We report a failure rate of 4.35% when using the iMRRN to segment tumor lesions within plain CT images in the lung cancer CT dataset. Seven classification algorithms were trained on the extracted radiomic features and tested for their ability to classify different lung cancer subtypes. Over-sampling was used to handle unbalanced data. Chi-square tests revealed the higher order texture features to be the most predictive when classifying lung cancers by subtype. The support vector machine showed the highest accuracy, 92.7% (0.97 AUC), when classifying three histological subtypes of lung cancer: adenocarcinoma, small cell carcinoma, and squamous cell carcinoma. The results demonstrate the potential of AI-based computer-aided diagnostic tools to automatically diagnose subtypes of lung cancer by coupling deep learning image segmentation with supervised classification. Our study demonstrated the integrated application of existing AI techniques in the non-invasive and effective diagnosis of lung cancer subtypes, and also shed light on several practical issues concerning the application of AI in biomedicine.
Collapse
Affiliation(s)
- Bryce Dunn
- Department of Bioengineering, George Mason University, Fairfax, VA 22030, USA
| | - Mariaelena Pierobon
- School of Systems Biology, Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, VA 22030, USA
| | - Qi Wei
- Department of Bioengineering, George Mason University, Fairfax, VA 22030, USA
| |
Collapse
|
7
|
Pasini G, Stefano A, Russo G, Comelli A, Marinozzi F, Bini F. Phenotyping the Histopathological Subtypes of Non-Small-Cell Lung Carcinoma: How Beneficial Is Radiomics? Diagnostics (Basel) 2023; 13:1167. [PMID: 36980475 PMCID: PMC10046953 DOI: 10.3390/diagnostics13061167] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2023] [Revised: 03/16/2023] [Accepted: 03/16/2023] [Indexed: 03/30/2023] Open
Abstract
The aim of this study was to investigate the usefulness of radiomics in the absence of well-defined standard guidelines. Specifically, we extracted radiomics features from multicenter computed tomography (CT) images to differentiate between the four histopathological subtypes of non-small-cell lung carcinoma (NSCLC). In addition, the results that varied with the radiomics model were compared. We investigated the presence of the batch effects and the impact of feature harmonization on the models' performance. Moreover, the question on how the training dataset composition influenced the selected feature subsets and, consequently, the model's performance was also investigated. Therefore, through combining data from the two publicly available datasets, this study involves a total of 152 squamous cell carcinoma (SCC), 106 large cell carcinoma (LCC), 150 adenocarcinoma (ADC), and 58 no other specified (NOS). Through the matRadiomics tool, which is an example of Image Biomarker Standardization Initiative (IBSI) compliant software, 1781 radiomics features were extracted from each of the malignant lesions that were identified in CT images. After batch analysis and feature harmonization, which were based on the ComBat tool and were integrated in matRadiomics, the datasets (the harmonized and the non-harmonized) were given as an input to a machine learning modeling pipeline. The following steps were articulated: (i) training-set/test-set splitting (80/20); (ii) a Kruskal-Wallis analysis and LASSO linear regression for the feature selection; (iii) model training; (iv) a model validation and hyperparameter optimization; and (v) model testing. Model optimization consisted of a 5-fold cross-validated Bayesian optimization, repeated ten times (inner loop). The whole pipeline was repeated 10 times (outer loop) with six different machine learning classification algorithms. Moreover, the stability of the feature selection was evaluated. Results showed that the batch effects were present even if the voxels were resampled to an isotropic form and whether feature harmonization correctly removed them, even though the models' performances decreased. Moreover, the results showed that a low accuracy (61.41%) was reached when differentiating between the four subtypes, even though a high average area under curve (AUC) was reached (0.831). Further, a NOS subtype was classified as almost completely correct (true positive rate ~90%). The accuracy increased (77.25%) when only the SCC and ADC subtypes were considered, as well as when a high AUC (0.821) was obtained-although harmonization decreased the accuracy to 58%. Moreover, the features that contributed the most to models' performance were those extracted from wavelet decomposed and Laplacian of Gaussian (LoG) filtered images and they belonged to the texture feature class.. In conclusion, we showed that our multicenter data were affected by batch effects, that they could significantly alter the models' performance, and that feature harmonization correctly removed them. Although wavelet features seemed to be the most informative features, an absolute subset could not be identified since it changed depending on the training/testing splitting. Moreover, performance was influenced by the chosen dataset and by the machine learning methods, which could reach a high accuracy in binary classification tasks, but could underperform in multiclass problems. It is, therefore, essential that the scientific community propose a more systematic radiomics approach, focusing on multicenter studies, with clear and solid guidelines to facilitate the translation of radiomics to clinical practice.
Collapse
Affiliation(s)
- Giovanni Pasini
- Department of Mechanical and Aerospace Engineering, Sapienza University of Rome, Eudossiana 18, 00184 Rome, Italy
- Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Contrada, Pietrapollastra-Pisciotto, 90015 Cefalù, Italy
| | - Alessandro Stefano
- Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Contrada, Pietrapollastra-Pisciotto, 90015 Cefalù, Italy
| | - Giorgio Russo
- Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Contrada, Pietrapollastra-Pisciotto, 90015 Cefalù, Italy
| | - Albert Comelli
- Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Contrada, Pietrapollastra-Pisciotto, 90015 Cefalù, Italy
- Ri.MED Foundation, Via Bandiera 11, 90133 Palermo, Italy
| | - Franco Marinozzi
- Department of Mechanical and Aerospace Engineering, Sapienza University of Rome, Eudossiana 18, 00184 Rome, Italy
| | - Fabiano Bini
- Department of Mechanical and Aerospace Engineering, Sapienza University of Rome, Eudossiana 18, 00184 Rome, Italy
| |
Collapse
|
8
|
Xiu D, Mo Y, Liu C, Hu Y, Wang Y, Zhao Y, Guo T, Cheng K, Huang C, Liu L, Cheng M. Integrative Nomogram of Computed Tomography Radiomics, Clinical, and Tumor Immune Features for Analysis of Disease-Free Survival of NSCLC Patients with Surgery. JOURNAL OF ONCOLOGY 2023; 2023:8607062. [PMID: 36866239 PMCID: PMC9974282 DOI: 10.1155/2023/8607062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/22/2022] [Revised: 08/10/2022] [Accepted: 11/25/2022] [Indexed: 02/23/2023]
Abstract
To improve prognosis of cancer patients and determine the integrative value for analysis of disease-free survival prediction, a clinic investigation was performed involving with 146 non-small cell lung cancer (NSCLC) patients (83 men and 73 women; mean age: 60.24 years ± 8.637) with a history of surgery. Their computed tomography (CT) radiomics, clinical records, and tumor immune features were firstly obtained and analyzed in this study. Histology and immunohistochemistry were also performed to establish a multimodal nomogram through the fitting model and cross-validation. Finally, Z test and decision curve analysis (DCA) were performed to evaluate and compare the accuracy and difference of each model. In all, seven radiomics features were selected to construct the radiomics score model. The clinicopathological and immunological factors model, including T stage, N stage, microvascular invasion, smoking quantity, family history of cancer, and immunophenotyping. The C-index of the comprehensive nomogram model on the training set and test set was 0.8766 and 0.8426 respectively, which was better than that of the clinicopathological-radiomics model (Z test, P =0.041<0.05), radiomics model and clinicopathological model (Z test, P =0.013<0.05 and P =0.0097<0.05). Integrative nomogram based on computed tomography radiomics, clinical and immunophenotyping can be served as effective imaging biomarker to predict DFS of hepatocellular carcinoma after surgical resection.
Collapse
Affiliation(s)
- Dianhui Xiu
- Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun 130021, China
| | - Yan Mo
- Deepwise AI Lab, Beijing Deepwise & League of PHD Technology Co. Ltd., Beijing 100080, China
| | - Chaohui Liu
- Deepwise AI Lab, Beijing Deepwise & League of PHD Technology Co. Ltd., Beijing 100080, China
| | - Yu Hu
- Department of Pathology, China-Japan Union Hospital of Jilin University, Changchun 130021, China
| | - Yanjing Wang
- Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun 130021, China
| | - Yiming Zhao
- Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun 130021, China
| | - Tiantian Guo
- Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun 130021, China
| | - Kailiang Cheng
- Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun 130021, China
| | - Chencui Huang
- Deepwise AI Lab, Beijing Deepwise & League of PHD Technology Co. Ltd., Beijing 100080, China
| | - Lin Liu
- Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun 130021, China
| | - Min Cheng
- Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun 130021, China
| |
Collapse
|
9
|
Practical Model for Residual/Recurrent Cervical Intraepithelial Lesions in Patients with Negative Margins after Cold-Knife Conization. J Clin Med 2022; 11:jcm11195634. [PMID: 36233503 PMCID: PMC9573483 DOI: 10.3390/jcm11195634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2022] [Revised: 09/04/2022] [Accepted: 09/20/2022] [Indexed: 11/30/2022] Open
Abstract
Objective: This study aimed to identify reliable risk factors for residual/recurrent cervical intraepithelial lesions in patients with negative margins after cold-knife conization. Methods: A total of 2352 women with HSILs (high-grade squamous intraepithelial lesions) with negative margins who underwent cold-knife conization between January 2014 and December 2020 were included; in total, 1411 women were assigned to the development cohort, and 941 women were assigned to the validation cohort. Multivariate logistic regression was used to build four predictive models based on the different combinations of follow-up data (Model A: preoperative factors; Model B: first-follow-up data; Model C: second-follow-up data; Model D: data from both follow-ups). The accuracy, sensitivity, specificity, false-positive rate (FPR), false-negative rate (FNR), and area under the receiver operating characteristic curve (AUC) were evaluated on the validation cohort. The predictive power of risk factors was further validated using six machine learning algorithms. Results: Model D demonstrated the highest AUC of 0.91 (95% CI, 0.87 to 0.96) in the validation cohort, whereas Models A, B, and C achieved AUCs of 0.69 (95% CI, 0.59 to 0.78), 0.88 (95% CI, 0.80 to 0.95), and 0.89 (95% CI, 0.81 to 0.97) respectively. The six machine learning methods achieved consistent results. Kaplan-Meier (KM) survival curves demonstrated that our models could effectively stratify patients with all models (p < 0.05 for all models). Conclusion: Our model, which is based on preoperative and follow-up factors, can serve as a complementary screening procedure for the early detection or prediction of recurrence after cold-knife conization in HSIL patients.
Collapse
|
10
|
Integrating Radiomics with Genomics for Non-Small Cell Lung Cancer Survival Analysis. JOURNAL OF ONCOLOGY 2022; 2022:5131170. [PMID: 36065309 PMCID: PMC9440821 DOI: 10.1155/2022/5131170] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/07/2022] [Revised: 06/14/2022] [Accepted: 07/11/2022] [Indexed: 11/18/2022]
Abstract
Purpose The objectives of our study were to assess the association of radiological imaging and gene expression with patient outcomes in non-small cell lung cancer (NSCLC) and construct a nomogram by combining selected radiomic, genomic, and clinical risk factors to improve the performance of the risk model. Methods A total of 116 cases of NSCLC with CT images, gene expression, and clinical factors were studied, wherein 87 patients were used as the training cohort, and 29 patients were used as an independent testing cohort. Handcrafted radiomic features and deep-learning genomic features were extracted and selected from CT images and gene expression analysis, respectively. Two risk scores were calculated through Cox regression models for each patient based on radiomic features and genomic features to predict overall survival (OS). Finally, a fusion survival model was constructed by incorporating these two risk scores and clinical factors. Results The fusion model that combined CT images, gene expression data, and clinical factors effectively stratified patients into low- and high-risk groups. The C-indexes for OS prediction were 0.85 and 0.736 in the training and testing cohorts, respectively, which was better than that based on unimodal data. Conclusions Combining radiomics and genomics can effectively improve OS prediction for NSCLC patients.
Collapse
|
11
|
Li H, Song Q, Gui D, Wang M, Min X, Li A. Reconstruction-assisted Feature Encoding Network for Histologic Subtype Classification of Non-small Cell Lung Cancer. IEEE J Biomed Health Inform 2022; 26:4563-4574. [PMID: 35849680 DOI: 10.1109/jbhi.2022.3192010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Accurate histological subtype classification between adenocarcinoma (ADC) and squamous cell carcinoma (SCC) using computed tomography (CT) images is of great importance to assist clinicians in determining treatment and therapy plans for non-small cell lung cancer (NSCLC) patients. Although current deep learning approaches have achieved promising progress in this field, they are often difficult to capture efficient tumor representations due to inadequate training data, and in consequence show limited performance. In this study, we propose a novel and effective reconstruction-assisted feature encoding network (RAFENet) for histological subtype classification by leveraging an auxiliary image reconstruction task to enable extra guidance and regularization for enhanced tumor feature representations. Different from existing reconstruction-assisted methods that directly use generalizable features obtained from shared encoder for primary task, a dedicated task-aware encoding module is utilized in RAFENet to perform refinement of generalizable features. Specifically, a cascade of cross-level non-local blocks are introduced to progressively refine generalizable features at different levels with the aid of lower-level task-specific information, which can successfully learn multi-level task-specific features tailored to histological subtype classification. Moreover, in addition to widely adopted pixel-wise reconstruction loss, we introduce a powerful semantic consistency loss function to explicitly supervise the training of RAFENet, which combines both feature consistency loss and prediction consistency loss to ensure semantic invariance during image reconstruction. Extensive experimental results show that RAFENet effectively addresses the difficult issues that cannot be resolved by existing reconstruction-based methods and consistently outperforms other state-of-the-art methods on both public and in-house NSCLC datasets.
Collapse
|
12
|
DETECT-LC: A 3D Deep Learning and Textural Radiomics Computational Model for Lung Cancer Staging and Tumor Phenotyping Based on Computed Tomography Volumes. APPLIED SCIENCES-BASEL 2022. [DOI: 10.3390/app12136318] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Lung Cancer is one of the primary causes of cancer-related deaths worldwide. Timely diagnosis and precise staging are pivotal for treatment planning, and thus can lead to increased survival rates. The application of advanced machine learning techniques helps in effective diagnosis and staging. In this study, a multistage neurobased computational model is proposed, DETECT-LC learning. DETECT-LC handles the challenge of choosing discriminative CT slices for constructing 3D volumes, using Haralick, histogram-based radiomics, and unsupervised clustering. ALT-CNN-DENSE Net architecture is introduced as part of DETECT-LC for voxel-based classification. DETECT-LC offers an automatic threshold-based segmentation approach instead of the manual procedure, to help mitigate this burden for radiologists and clinicians. Also, DETECT-LC presents a slice selection approach and a newly proposed relatively light weight 3D CNN architecture to improve existing studies performance. The proposed pipeline is employed for tumor phenotyping and staging. DETECT-LC performance is assessed through a range of experiments, in which DETECT-LC attains outstanding performance surpassing its counterparts in terms of accuracy, sensitivity, F1-score and Area under Curve (AuC). For histopathology classification, DETECT-LC average performance achieved an improvement of 20% in overall accuracy, 0.19 in sensitivity, 0.16 in F1-Score and 0.16 in AuC over the state of the art. A similar enhancement is reached for staging, where higher overall accuracy, sensitivity and F1-score are attained with differences of 8%, 0.08 and 0.14.
Collapse
|
13
|
Wu YJ, Wu FZ, Yang SC, Tang EK, Liang CH. Radiomics in Early Lung Cancer Diagnosis: From Diagnosis to Clinical Decision Support and Education. Diagnostics (Basel) 2022; 12:diagnostics12051064. [PMID: 35626220 PMCID: PMC9139351 DOI: 10.3390/diagnostics12051064] [Citation(s) in RCA: 28] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2022] [Revised: 04/14/2022] [Accepted: 04/22/2022] [Indexed: 12/19/2022] Open
Abstract
Lung cancer is the most frequent cause of cancer-related death around the world. With the recent introduction of low-dose lung computed tomography for lung cancer screening, there has been an increasing number of smoking- and non-smoking-related lung cancer cases worldwide that are manifesting with subsolid nodules, especially in Asian populations. However, the pros and cons of lung cancer screening also follow the implementation of lung cancer screening programs. Here, we review the literature related to radiomics for early lung cancer diagnosis. There are four main radiomics applications: the classification of lung nodules as being malignant/benign; determining the degree of invasiveness of the lung adenocarcinoma; histopathologic subtyping; and prognostication in lung cancer prediction models. In conclusion, radiomics offers great potential to improve diagnosis and personalized risk stratification in early lung cancer diagnosis through patient–doctor cooperation and shared decision making.
Collapse
Affiliation(s)
- Yun-Ju Wu
- Department of Software Engineering and Management, National Kaohsiung Normal University, Kaohsiung 80201, Taiwan;
| | - Fu-Zong Wu
- Institute of Education, National Sun Yat-Sen University, 70, Lien-Hai Road, Kaohsiung 804241, Taiwan;
- Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan
- Faculty of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan
- Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan
- Correspondence:
| | - Shu-Ching Yang
- Institute of Education, National Sun Yat-Sen University, 70, Lien-Hai Road, Kaohsiung 804241, Taiwan;
| | - En-Kuei Tang
- Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813414, Taiwan;
| | - Chia-Hao Liang
- Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan;
| |
Collapse
|
14
|
Luo Y, Li Y, Zhang Y, Zhang J, Liang M, Jiang L, Guo L. Parameter tuning in machine learning based on radiomics biomarkers of lung cancer. JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY 2022; 30:477-490. [PMID: 35342074 DOI: 10.3233/xst-211096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
BACKGROUND Lung cancer is one of the most common cancers, and early diagnosis and intervention can improve cancer cure rate. OBJECTIVE To improve predictive performance of radiomics features for lung cancer by tuning the machine learning model parameters. METHODS Using a dataset involving 263 cases (125 benign and 138 malignant) acquired from our hospital, each classifier model is trained and tested using 237 and 26 cases, respectively. We initially extract 867 radiomics features of CT images for model development and then test 10 feature selections and 7 models to determine the best method. We further tune the parameter of the final model to reach the best performance. The adjusted final model is then validated using 224 cases acquired from Lung Image Database Consortium (LIDC) dataset (64 benign and 160 malignant) with the same set of selected radiomics features. RESULTS During model development, the feature selection via concave minimization method show the best performance of area under ROC curve (AUC = 0.765), followed by l0-norm regularization (AUC = 0.741) and Fisher discrimination criterion (AUC = 0.734). Support vector machine (SVM) and random forest (RF) are the top two machine learning algorithms showing the best performance (AUC = 0.765 and 0.734, respectively), using by the default parameter. After parameter tuning, SVM with linear kernel achieves the best performance (AUC = 0.837), whereas the best tuned RF with the number of trees is 510 and yields a slightly lower performance (AUC = 0.775) in 26 test samples data. During model validation, the SVM and RF models yield AUC = 0.78 and 0.77, respectively. CONCLUSION Appropriate quantitative radiomics features and accurate parameters can improve the model's performance to predict lung cancer.
Collapse
Affiliation(s)
- Yuan Luo
- School of Medical Imaging, Tianjin Medical University, Tianjin, China
| | - Yifan Li
- School of Medical Imaging, Tianjin Medical University, Tianjin, China
| | - Yuwei Zhang
- School of Medical Imaging, Tianjin Medical University, Tianjin, China
| | - Jianwei Zhang
- Department of Radiology, Tianjin Baodi Hospital, Tianjin, China
| | - Meng Liang
- School of Medical Imaging, Tianjin Medical University, Tianjin, China
| | - Lin Jiang
- School of Medical Imaging, Tianjin Medical University, Tianjin, China
| | - Li Guo
- School of Medical Imaging, Tianjin Medical University, Tianjin, China
| |
Collapse
|
15
|
Kang CY, Duarte SE, Kim HS, Kim E, Park J, Lee AD, Kim Y, Kim L, Cho S, Oh Y, Gim G, Park I, Lee D, Abazeed M, Velichko YS, Chae YK. OUP accepted manuscript. Oncologist 2022; 27:e471-e483. [PMID: 35348765 PMCID: PMC9177100 DOI: 10.1093/oncolo/oyac036] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2021] [Accepted: 01/14/2022] [Indexed: 11/17/2022] Open
Abstract
The recent, rapid advances in immuno-oncology have revolutionized cancer treatment and spurred further research into tumor biology. Yet, cancer patients respond variably to immunotherapy despite mounting evidence to support its efficacy. Current methods for predicting immunotherapy response are unreliable, as these tests cannot fully account for tumor heterogeneity and microenvironment. An improved method for predicting response to immunotherapy is needed. Recent studies have proposed radiomics—the process of converting medical images into quantitative data (features) that can be processed using machine learning algorithms to identify complex patterns and trends—for predicting response to immunotherapy. Because patients undergo numerous imaging procedures throughout the course of the disease, there exists a wealth of radiological imaging data available for training radiomics models. And because radiomic features reflect cancer biology, such as tumor heterogeneity and microenvironment, these models have enormous potential to predict immunotherapy response more accurately than current methods. Models trained on preexisting biomarkers and/or clinical outcomes have demonstrated potential to improve patient stratification and treatment outcomes. In this review, we discuss current applications of radiomics in oncology, followed by a discussion on recent studies that use radiomics to predict immunotherapy response and toxicity.
Collapse
Affiliation(s)
| | | | - Hye Sung Kim
- Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Eugene Kim
- Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | | | - Alice Daeun Lee
- Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Yeseul Kim
- Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Leeseul Kim
- Department of Internal Medicine, AMITA Health Saint Francis Hospital, Evanston, IL, USA
| | - Sukjoo Cho
- Department of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, FL, USA
| | - Yoojin Oh
- Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Gahyun Gim
- Department of Hematology and Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA
| | - Inae Park
- Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Dongyup Lee
- Department of Physical Medicine and Rehabilitation, Geisinger Health System, Danville, PA, USA
| | - Mohamed Abazeed
- Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Yury S Velichko
- Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Young Kwang Chae
- Corresponding author: Young Kwang Chae, Department of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
| |
Collapse
|
16
|
Deep Radiotranscriptomics of Non-Small Cell Lung Carcinoma for Assessing Molecular and Histology Subtypes with a Data-Driven Analysis. Diagnostics (Basel) 2021; 11:diagnostics11122383. [PMID: 34943617 PMCID: PMC8700168 DOI: 10.3390/diagnostics11122383] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2021] [Revised: 12/15/2021] [Accepted: 12/16/2021] [Indexed: 11/17/2022] Open
Abstract
Radiogenomic and radiotranscriptomic studies have the potential to pave the way for a holistic decision support system built on genomics, transcriptomics, radiomics, deep features and clinical parameters to assess treatment evaluation and care planning. The integration of invasive and routine imaging data into a common feature space has the potential to yield robust models for inferring the drivers of underlying biological mechanisms. In this non-small cell lung carcinoma study, a multi-omics representation comprised deep features and transcriptomics was evaluated to further explore the synergetic and complementary properties of these diverse multi-view data sources by utilizing data-driven machine learning models. The proposed deep radiotranscriptomic analysis is a feature-based fusion that significantly enhances sensitivity by up to 0.174 and AUC by up to 0.22, compared to the baseline single source models, across all experiments on the unseen testing set. Additionally, a radiomics-based fusion was also explored as an alternative methodology yielding radiomic signatures that are comparable to several previous publications in the field of radiogenomics. Furthermore, the machine learning multi-omics analysis based on deep features and transcriptomics achieved an AUC performance of up to 0.831 ± 0.09/0.925 ± 0.04 for the examined molecular and histology subtypes analysis, respectively. The clinical impact of such high-performing models can add prognostic value and lead to optimal treatment assessment by targeting specific oncogenes, namely the response of tyrosine kinase inhibitors of EGFR mutated or predicting the chemotherapy resistance of KRAS mutated tumors.
Collapse
|
17
|
Barragán-Montero A, Javaid U, Valdés G, Nguyen D, Desbordes P, Macq B, Willems S, Vandewinckele L, Holmström M, Löfman F, Michiels S, Souris K, Sterpin E, Lee JA. Artificial intelligence and machine learning for medical imaging: A technology review. Phys Med 2021; 83:242-256. [PMID: 33979715 PMCID: PMC8184621 DOI: 10.1016/j.ejmp.2021.04.016] [Citation(s) in RCA: 96] [Impact Index Per Article: 32.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/06/2020] [Revised: 04/15/2021] [Accepted: 04/18/2021] [Indexed: 02/08/2023] Open
Abstract
Artificial intelligence (AI) has recently become a very popular buzzword, as a consequence of disruptive technical advances and impressive experimental results, notably in the field of image analysis and processing. In medicine, specialties where images are central, like radiology, pathology or oncology, have seized the opportunity and considerable efforts in research and development have been deployed to transfer the potential of AI to clinical applications. With AI becoming a more mainstream tool for typical medical imaging analysis tasks, such as diagnosis, segmentation, or classification, the key for a safe and efficient use of clinical AI applications relies, in part, on informed practitioners. The aim of this review is to present the basic technological pillars of AI, together with the state-of-the-art machine learning methods and their application to medical imaging. In addition, we discuss the new trends and future research directions. This will help the reader to understand how AI methods are now becoming an ubiquitous tool in any medical image analysis workflow and pave the way for the clinical implementation of AI-based solutions.
Collapse
Affiliation(s)
- Ana Barragán-Montero
- Molecular Imaging, Radiation and Oncology (MIRO) Laboratory, UCLouvain, Belgium.
| | - Umair Javaid
- Molecular Imaging, Radiation and Oncology (MIRO) Laboratory, UCLouvain, Belgium
| | - Gilmer Valdés
- Department of Radiation Oncology, Department of Epidemiology and Biostatistics, University of California, San Francisco, USA
| | - Dan Nguyen
- Medical Artificial Intelligence and Automation (MAIA) Laboratory, Department of Radiation Oncology, UT Southwestern Medical Center, USA
| | - Paul Desbordes
- Information and Communication Technologies, Electronics and Applied Mathematics (ICTEAM), UCLouvain, Belgium
| | - Benoit Macq
- Information and Communication Technologies, Electronics and Applied Mathematics (ICTEAM), UCLouvain, Belgium
| | - Siri Willems
- ESAT/PSI, KU Leuven Belgium & MIRC, UZ Leuven, Belgium
| | | | | | | | - Steven Michiels
- Molecular Imaging, Radiation and Oncology (MIRO) Laboratory, UCLouvain, Belgium
| | - Kevin Souris
- Molecular Imaging, Radiation and Oncology (MIRO) Laboratory, UCLouvain, Belgium
| | - Edmond Sterpin
- Molecular Imaging, Radiation and Oncology (MIRO) Laboratory, UCLouvain, Belgium; KU Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Belgium
| | - John A Lee
- Molecular Imaging, Radiation and Oncology (MIRO) Laboratory, UCLouvain, Belgium
| |
Collapse
|